Reshaping the future of cancer therapy: taming toxicity and side effects

Cancer continues to pose a formidable challenge in global health, with conventional treatments such as chemotherapy and radiotherapy often resulting in severe toxicities that significantly degrade patients’ quality of life and restrict therapeutic outcomes. Addressing this pressing issue, this review presents a thorough and systematic analysis of innovative and emerging strategies designed to minimize the toxicity induced by treatment, while maintaining or even enhancing antitumor efficacy. The focus is on six promising therapeutic approaches: combination therapies utilizing natural bioactive products, molecularly targeted therapies, immunotherapies, nanotechnology-mediated drug delivery systems, adjunct traditional Chinese medicine interventions, and low-dose spatiotemporally concerted regimens. Each approach employs unique mechanisms—such as enhanced targeting precision, immune system activation, tumor microenvironment reprogramming, and multi-component synergistic effects—to mitigate damage to normal tissues and reduce systemic adverse reactions. Despite promising preclinical and clinical advancements, several challenges persist, including drug resistance, high economic costs, a lack of reliable predictive biomarkers, and complexities in clinical translation and regulatory approval. Looking ahead, the incorporation of artificial intelligence, multi-omics profiling, and novel biomimetic nanotechnologies offers unprecedented opportunities for developing highly personalized, low-toxicity treatment frameworks. This review highlights a fundamental shift in oncology towards precision medicine that balances efficacy with safety, demonstrating the transformative potential of these strategies in shaping the future of cancer therapy and enhancing patient care globally.